Table 2. Univariate and multivariate analysis of disease-free survival (dfs) and overall survival (os) in training cohort.
Variables | DFS | OS | |||||||
---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | ||||||
HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P | ||
Tumor size (cm) | < 8 vs. > 8 | 2.041 (1.340–3.108) | 0.001 | 1.831 (1.173–2.860) | 0.008 | 2.115 (1.329–3.367) | 0.002 | 1.723(1.045–2.841) | 0.033 |
Histologic grade | Low vs. High | 1.606 (1.051–2.455) | 0.029 | 1.620(0.985–2.666) | 0.058 | 1.669 (1.049–2.657) | 0.031 | 1.788 (1.109–2.881) | 0.017 |
TNM stage | I/II vs. III | 2.446(1.599-3.740) | < 0.001 | 1.976(1.280-3.052) | 0.002 | 2.139(1.341–3.412) | 0.001 | 1.951(1.216-3.129) | 0.006 |
PRDX1 expression | Low vs. High | 2.114 (1.359–3.289) | 0.001 | 1.845 (1.191–2.856) | 0.006 | 1.951 (1.187–3.208) | 0.008 | 1.938(1.197–3.138) | 0.007 |